These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of pituitary adenylate cyclase activating polypeptide (PACAP) on amylase secretion from guinea pig pancreatic acini. Kitagawa M; Naruse S; Ishiguro H; Hayakawa T; Nokihara K Biomed Pept Proteins Nucleic Acids; 1995; 1(2):73-6. PubMed ID: 9346857 [TBL] [Abstract][Full Text] [Related]
4. Comparison between the effects of VIP and the novel peptide PACAP on the exocrine pancreatic secretion of the rat. Alonso RM; Rodríguez AM; García LJ; López MA; Calvo JJ Pancreas; 1994 Jan; 9(1):123-8. PubMed ID: 7509062 [TBL] [Abstract][Full Text] [Related]
5. An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neuro-transmitters in exocrine pancreas of rats. Wheeler S; Eardley JE; McNulty KF; Sutcliffe CP; Morrison JD Exp Physiol; 1997 Jul; 82(4):729-47. PubMed ID: 9257115 [TBL] [Abstract][Full Text] [Related]
6. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig. Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442 [TBL] [Abstract][Full Text] [Related]
7. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex. Zawilska JB; Niewiadomski P; Nowak JZ Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071 [TBL] [Abstract][Full Text] [Related]
8. Effect of pituitary adenylate cyclase activating polypeptide on rat pancreatic exocrine secretion. Mungan Z; Ertan A; Hammer RA; Arimura A Peptides; 1991; 12(3):559-62. PubMed ID: 1717954 [TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433 [TBL] [Abstract][Full Text] [Related]
10. PACAP stimulates pancreatic exocrine secretion via the vagal cholinergic nerves in sheep. Onaga T; Okamoto K; Harada Y; Mineo H; Kato S Regul Pept; 1997 Oct; 72(2-3):147-53. PubMed ID: 9652974 [TBL] [Abstract][Full Text] [Related]
11. Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout. Le Mével JC; Lancien F; Mimassi N; Conlon JM J Exp Biol; 2009 Dec; 212(Pt 23):3919-27. PubMed ID: 19915135 [TBL] [Abstract][Full Text] [Related]
12. The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs. Ito O; Naruse S; Kitagawa M; Ishiguro H; Ko S; Nakajima M; Hayakawa T Regul Pept; 1998 Nov; 78(1-3):105-12. PubMed ID: 9879753 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus. Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400 [TBL] [Abstract][Full Text] [Related]
14. Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs. Konturek SJ; Thor P; Dembinski A; Krol R Gastroenterology; 1975 Jun; 68(6):1527-35. PubMed ID: 1132634 [TBL] [Abstract][Full Text] [Related]
15. The effect of pituitary adenylate cyclase activating polypeptide (PACAP) on exocrine pancreatic secretion in dogs. Naruse S; Suzuki T; Ozaki T Pancreas; 1992; 7(5):543-7. PubMed ID: 1513802 [TBL] [Abstract][Full Text] [Related]
16. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor. Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926 [TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells. Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945 [TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009 [TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide: a secretin-like partial agonist for pancreatic secretion in man. Domschke S; Domschke W; Rösch W; Konturek SJ; Sprügel W; Mitznegg P; Wünsch E; Demling L Gastroenterology; 1977 Sep; 73(3):478-80. PubMed ID: 892345 [TBL] [Abstract][Full Text] [Related]
20. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells. Delgado M; Reduta A; Sharma V; Ganea D J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]